LSTA
USDLisata Therapeutics Inc. Common Stock
$2.530-0.010 (-0.394%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.540
High
$2.605
Low
$2.430
Volume
0.04M
Company Fundamentals
Market Cap
22.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.04M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.87Current $2.530High $4.2
Related News
GlobeNewswire
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent
BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of
View more
GlobeNewswire
Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
BASKING RIDGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.